Spyre Therapeutics, Inc. · NASDAQ:SYRE

Perceptive Advisors LLC's stake in Spyre Therapeutics, Inc. fell to 4.40% (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

Perceptive Advisors LLC's stake in Spyre Therapeutics, Inc. fell to 4.40%, 2,574,723 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
4.40%
Shares
2,574,723
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Perceptive Advisors LLC4.40%2,574,723
Joseph Edelman4.40%2,574,723
Perceptive Life Sciences Master Fund, Ltd.4.40%2,574,723

Source

View original at SEC

Related